Wednesday, April 30, 2025
4/30/2025
Leveraging an academic-industry partnership to develop a cancer-specific mobile meditation app - 1 Project Summary/Abstract 2 Approximately 15.5 million US cancer patients/survivors experience a host of residual symptoms (e.g., 3 fatigue, anxiety, depression, pain, sleep disturbance) and reduced quality of life that are often not resolved with 4 even the best-available current standard of care therapies. Residual symptom burden impairs cancer survivor 5 functioning and leads to increased rates of disability and healthcare utilization, costing $125 billion every year. 6 Cancer patients/survivors want and need complementary strategies to accompany standard therapies. 7 Research has demonstrated the benefits of mindfulness-based therapies, such as meditation, for 8 alleviating cancer-related symptoms (e.g., fatigue, anxiety, depression, and sleep disturbance).Meditation-based 9 programs are typically conducted in-person, in clinic settings; however, these programs are expensive and 10 difficult to sustain, and cancer patients report barriers to participating (e.g., travel demands, fatigue, pain, and 11 scheduling difficulties). Smartphone-based meditation is a feasible and novel method for delivering meditation 12 to cancer patients/survivors. Mobile apps and online meditation programs have demonstrated short-term benefits 13 for cancer patients/survivors; however, the currently available commercial meditation apps are limited in their 14 engagement, acceptability, and applicability to cancer patients/survivors’ unique experiences and have not been 15 evaluated for feasibility or efficacy. There is an unmet need for a commercially-available, evidence-based 16 meditation app specifically designed for cancer patients/survivors. Incorporating stakeholder feedback (i.e., 17 patients and healthcare providers) in the early design phase will facilitate the development of a meditation app 18 truly targeted for the end users that can be made commercially available, thereby improving uptake and impact 19 in patient populations. Calm, a popular consumer-based meditation app with 70 million downloads and 2 million 20 subscribers, provides a platform from which to develop an accessible standalone cancer-specific meditation app. 21 This project will: 1) gather feedback about the current Calm app from an advisory committee (N=20) consisting 22 of cancer patients/survivors (n=10, 5 of each) and healthcare providers (n=10), 2) design a cancer-specific 23 meditation app prototype, and 3) beta-test the prototype in cancer patients/survivors (N=30). 24 A standalone meditation app designed for and tested by cancer patients/survivors, leveraging a popular 25 and validated meditation app platform, to be made commercially available, is innovative and could provide a 26 scalable, highly engaging symptom-management tool that addresses cancer patients/survivors’ unique needs. 27 If our key feasibility milestones are met, we will further refine the cancer-specific app and conduct a randomized 28 controlled trial to determine the app’s long-term efficacy in reducing symptom burden in cancer patients/survivors 29 (Phase 2) that can later be commercialized and marketed to cancer patients/survivors, healthcare providers, and 30 clinics. (Phase 3).
HHS’ Tracking Accountability in Government Grants System (TAGGS) website provides access to detailed descriptions of grants, loans, aggregated direct payments and other types of financial assistance awarded by the HHS Operating Divisions (OPDIVs) and the Office of the Secretary Staff Divisions (STAFFDIVs).